Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort - Takeaways - MDSpire

Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort

  • By

  • Roberta Elisa Rossi

  • Matteo Ferraris

  • Lorenzo Petronio

  • Benedetta Masoni

  • Luca Di Stefano

  • Alexia Francesca Bertuzzi

  • Sara Fraticelli

  • Andrea Gerardo Antonio Lania

  • Alessandro Zerbi

  • Cesare Hassan

  • Alessandro Repici

  • July 7, 2026

  • 0 min

Share

  • 1

    Among 175 patients with autoimmune atrophic gastritis, 16% were diagnosed with type I gastric neuroendocrine tumors.

  • 2

    ECL cell hyperplasia was identified as the strongest histological factor associated with the development of T1gNETs.

  • 3

    Dyspeptic symptoms were inversely correlated with T1gNET occurrence, indicating many patients were asymptomatic.

  • 4

    No significant predictive value was found for smoking, alcohol, BMI, or severe hypergastrinemia/CgA levels in relation to T1gNETs.

  • 5

    The study suggests a need for further data to standardize endoscopic surveillance protocols for patients with AIG.

Original Source(s)

Factors associated with type 1 gastric neuroendocrine tumor occurrence in autoimmune atrophic gastritis: insights from a real-world cohort

  • by Roberta Elisa Rossi, Matteo Ferraris, Lorenzo Petronio, Benedetta Masoni, Luca Di Stefano, Alexia Francesca Bertuzzi, Sara Fraticelli, Andrea Gerardo Antonio Lania, Alessandro Zerbi, Cesare Hassan, Alessandro Repici

  • July 7, 2026

Related Content

Case Report: A case of incidentally discovered isolated gastric plasmacytoma

Improving CT-CBCT deformable image registration for cervical cancer adaptive radiotherapy using a deep learning approach

BAG3+ CAF-T cell neighborhood predicts resistance to neoadjuvant chemoimmunotherapy in NSCLC